<VariationArchive VariationID="3245992" VariationName="NC_000006.11:g.(?_123892048)_(123957920_?)del" VariationType="Deletion" Accession="VCV003245992" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3403705" VariationID="3245992">
      <GeneList>
        <Gene Symbol="TRDN" FullName="triadin" GeneID="10345" HGNC_ID="HGNC:12261" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="123216339" stop="123636950" display_start="123216339" display_stop="123636950" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="123537483" stop="123958237" display_start="123537483" display_stop="123958237" Strand="-" />
          </Location>
          <OMIM>603283</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000006.11:g.(?_123892048)_(123957920_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="123892048" innerStop="123957920" display_start="123892048" display_stop="123957920" variantLength="65873" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_123892048)_(123957920_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_123892048)_(123957920_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.11:g.(?_123892048)_(123957920_?)del AND Catecholaminergic polymorphic ventricular tachycardia 1" Accession="RCV004578635" Version="1">
        <ClassifiedConditionList TraitSetID="6589">
          <ClassifiedCondition DB="MedGen" ID="C1631597">Catecholaminergic polymorphic ventricular tachycardia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22422768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25922419</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26200674</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30649896</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Stress-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 1</ElementValue>
                <XRef ID="MONDO:0011484" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CPVT1</ElementValue>
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C1631597" DB="MedGen" />
              <XRef ID="MONDO:0011484" DB="MONDO" />
              <XRef Type="MIM" ID="604772" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9836523" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000006.11:g.(?_123892048)_(123957920_?)del|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005066137" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22422768</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25922419</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26200674</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30649896</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with TRDN-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 1-2 of the TRDN gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRDN are known to be pathogenic (PMID: 22422768, 25922419, 26200674, 30649896).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_123892048)_(123957920_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9836523" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

